PFA-100 closure times in preoperative screening in 500 pediatric patients

Thrombosis and Haemostasis

Volumn 98, Issue 1, 2007, Pages 243-247

  Roschitz, Birgit ^a   Thaller, Sigrid ^b   Koestenberger, Martin ^a   Wirnsberger, Andrea ^a   Leschnik, Bettina ^a   Fritsch, Peter ^a   Muntean, Wolfgang ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b UNIVERSITY OF GRAZ   (Austria)

Author keywords

Closure time; Paediatric haemostasis; Von willebrand disease

Indexed keywords

BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 8; RISTOCETIN COFACTOR; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR;

ADOLESCENT; ADULT; ARTICLE; BLOOD CELL COUNT; BLOOD CLOTTING DISORDER; BLOOD CLOTTING TEST; CHILD; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HEMOSTASIS; HIGH RISK PATIENT; HUMAN; INFANT; INTERMETHOD COMPARISON; LABORATORY TEST; MAJOR CLINICAL STUDY; MEDICAL INSTRUMENTATION; OUTPATIENT; PARTIAL THROMBOPLASTIN TIME; PEDIATRIC SURGERY; POSTOPERATIVE HEMORRHAGE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; SENSITIVITY AND SPECIFICITY; SURGICAL PATIENT; VON WILLEBRAND DISEASE;

ADOLESCENT; ADULT; BLOOD CELL COUNT; BLOOD COAGULATION TESTS; BLOOD LOSS, SURGICAL; CHILD; CHILD, PRESCHOOL; HEMOSTASIS; HUMANS; INFANT; MASS SCREENING; PARTIAL THROMBOPLASTIN TIME; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE; VON WILLEBRAND DISEASE;

EID: 34447521865     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH-09-0493     Document Type: Article

References (28)

1. Koscielny J, Ziemer S, Radtke H, et al. A practical concept for preoperative identification of patients with impaired primary hemostasis. Clin Appl Thromb Hemost 2004; 10: 195-204.
2. Chee YL, Greaves M. Role of coagulation testing in predicting bleeding risk. Hematol J 2003; 4: 373-378.
3. Houry S, Georgeac C, Hay JM, et al. A prospective multi-center evaluation of preoperative hemostatic screening tests. Am J Sing 1995; 170: 19-23.
4. Kitchens CS. To bleed or not to bleed? Is that the question for the PTT? J Thromb Haemost 2005; 3: 2607-2611.
5. Cochrane AL, Chapmann PJ, Oldham PD. Observers errors in taking medical histories. Lancet 1951; 260: 1007-1009.
6. Montgomery RR, Kroner PA. von Willebrand disease: a common pediatric disorder. Pediatr Ann 2001; 30: 534-540.
7. Sutor AH. The bleeding time in pediatrics. Semin Thromb Hemost 1998; 24: 531-543.
8. Kundu SK, Heilmann EJ, Sio, R, et al. Characterisation of an in vitro platelet analyser, PFA-100. Clin Appl Thromb Hemost 1996; 2: 241-249.
9. Fressinaud E, Veyradier A, Truchaud F, et al. Screening for von Willebrand disease with a new analyzer using high shear stress: a study of 60 cases. Blood 1998; 91: 1325-1331.
10. Cattaneo M, Federici AB, Lecchi A, et al. Evaluation of the PFA-100 system in the diagnosis and therapeutic monitoring of patients with von Willebrand disease. Thromb Haemost 1999; 82: 35-39.
11. Dean JA, Blanchette VS, Carcao MD, et al. von Willebrand disease in a pediatric-based population - comparison of type 1 diagnostic criteria and use of the PFA-100 and a von Willebrand factor/collagen-binding assay. Thromb Haemost 2000; 84: 401-409.
12. Gallistl S, Muntean W, Leschnik B, et al. Longer aPTT values in healthy children than in adults: no single cause. Thromb Res 1997; 88: 355-359.
13. Muntean W, Finding K, Leschnik B. Partial thromboplastin times are longer in healthy children than in adults. Thromb Haemorrh Disorders 1992; 6: 23-25.
14. Carcao M, Blanchette VS, Dean JA, et al. The platelet function analyzer (PFA-100) a novel in-vitro system for evaluation of primary haemostasis. Br J Haematol 1998; 101: 70-73.
15. Mammen EF, Comp PC, Gosselin R, et al. PFA-100 system: a new method for assessment of platelet function. Semin Thromb Hemost 1998; 24: 195-202.
16. Roschitz B, Sudi K, Kostenberger M, et al. Shorter PFA-100 closure times in neonates than in adults: role of red cells, white cells, platelets and von Willebrand factor. Acta Paediatr 2001; 90: 664-670.
17. Vincentelli A, Susen S, Le Tourneau T, et al. Acquired von Willebrand syndrome in aortic stenosis. N Engl J Med 2003; 349: 343-349.
18. Hayward CPM, Harrison P, Cattaneo M, et al. Platelet function analyzer (PFA)-100 closure time in the evaluation of platelet disorders and platelet function. J Thromb Haemost 2006; 4: 312-319.
19. Koscielny J, Kiesewetter H, Tempelhoff GF. More on: platelet function analyzer (PFA)-100 closure time in the evaluation of platelet disorders and platelet function. J Thromb Haemost 2006; 4: 1426-1427.
20. Serebruany VL. Platelet function analyzer (PFA)-100 closure time in the evaluation of platelet disorders and platelet function: a rebuttal. J Thromb Haemost 2006; 4: 1428-1429.
21. Kratzer MAA, Kretschmer V. Platelet function analyzer (PFA)-100 closure time in the evaluation of platelet disorders and platelet function- a rebuttal. J Thromb Haemost 2006; 4: 1429-1431.
22. Hayward CPM, Harrison P, Cattaneo M, et al. Platelet function analyzer (PFA)-100 closure time in the evaluation of platelet disorders and platelet function: reply to a rebuttal. J Thromb Haemost 2006; 4: 1433-1434.
23. Manning SC, Beste D, McBride T, et al. An assessment of preoperative coagulation screening for tonsillectomy and adenoidectomy. Int J Pediatr Otorhinolaryngol 1987; 13: 237-244.
24. Werner EJ, Broxson EH, Tucker EL, et al. Prevalence of von Willebrand disease in children: a multiethnic study. J Pediatr 1993; 123: 893-898.
25. Rodeghiero F, Castamann G, Dini E. Epidemiological investigation of the prevalence of von Willebrand's disease. Blood 1987; 69: 545-549.
26. Harrison P. The role of PFA-100 testing in the investigation and management of haemostatic defects in children and adults. Br J Haematol 2005; 130: 3-10.
27. Mizumoto H, Maihara T, Hiejima E, et al. Transient antiphospholipid antibodies associated with acute infections in children: a report of three cases and a review of the literature. Eur J Pediatr 2006; 165: 484-488.
28. Edlinger G, Gallistl S, Muntean W. Lupus anticoagulant and factor XII acitivity in children with prolonged PTT. Thromb Res 1996; 5: 403-404.